Arrested for any crime at 6 months · summary findings of female review
It is very uncertain whether cognitive behavioural therapy and other therapies changes arrested for any crime at 6 months compared with prison therapeutic community (very low certainty).
1 finding from 1 review
Criminal Activity · summary findings of female review
It is very uncertain whether cognitive behavioural therapy and other therapies changes criminal activity at 6 months compared with prison therapeutic community (very low certainty).
1 finding from 1 review
Drug‐related crime at 6 months · summary findings of female review
It is very uncertain whether cognitive behavioural therapy and other therapies changes drug‐related crime at 6 months compared with prison therapeutic community (very low certainty).
1 finding from 1 review
Arrested (not parole violation) at 6 months · summary findings of female review
It is very uncertain whether cognitive behavioural therapy and other therapies changes arrested (not parole violation) at 6 months compared with prison therapeutic community (very low certainty).
1 finding from 1 review
Drug use · summary findings of female review
It is very uncertain whether cognitive behavioural therapy and other therapies changes self‐reported drug use at 6 months compared with prison therapeutic community (very low certainty).
1 finding from 1 review
Reincarcerated at 12 months after parole · summary findings of female review
Cognitive behavioural therapy and other therapies showed no clear difference in reincarcerated at 12 months after parole compared with prison therapeutic community (low certainty).
1 finding from 1 review
Change in weight (kg) · People who have quit smoking
Nicotine replacement therapy for smoking cessation showed no clear difference in mean weight change (kg) at end of treatment compared with placebo (moderate certainty).
3 findings from 1 review
MD 0.52
21 studies · 2784 participants
Moderate
MD 0.08
11 studies · 1021 participants
Moderate
MD 0.37
17 studies · 1463 participants
Moderate
Substance use ‐ relapse · co‐occurring depression and substance use disorders
It is very uncertain whether interpersonal Psychotherapy for Depression (IPT‐D) changes substance use ‐ relapse compared with other Psychological Interventions (very low certainty).
1 finding from 1 review
Retention in treatment · co‐occurring depression and substance use disorders
It is very uncertain whether interpersonal Psychotherapy for Depression (IPT‐D) changes treatment retention compared with other Psychological Interventions (very low certainty).
1 finding from 1 review
Depression score · co‐occurring depression and substance use disorders
2 findings from 1 review
Percent of days abstinent · co‐occurring depression and substance use disorders
1 finding from 1 review
Incarceration at 3 months · summary findings of female review
It is very uncertain whether cognitive behavioural therapy and standard therapy changes incarceration at 3 months compared with treatment (very low certainty).
2 findings from 1 review
ASI drug score at 6 months · summary findings of female review
2 findings from 1 review
Repetition of SH at post‐intervention · self‐harm in adults
Comparison 1.2: Group‐based CBT‐based psychotherapy showed no clear difference in repetition of SH at post‐intervention compared with TAU or another comparator (moderate certainty).
1 finding from 1 review
Complete cure, at least 3 months after the end of treatment · People with American cutaneous leishmaniasis
Thermotherapy one session (at 50 ºC for 30 seconds) leads to lower complete cure, at least 3 months after the end of treatment compared with meglumine antimoniate (20 mg Sb5/kg/day (high certainty).
1 finding from 1 review
Adverse effects · People with American cutaneous leishmaniasis
1 finding from 1 review
Recurrence ‐ not measured · People with American cutaneous leishmaniasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death Number of deaths over 36 months · stage III and IV cutaneous melanoma
It is very uncertain whether neoadjuvant immunotherapy (talimogene laherparepvec) changes overall survival (OS), measured by the number of deaths over time, compared with no neoadjuvant treatment (very low certainty).
1 finding from 1 review
Adverse events, · stage III and IV cutaneous melanoma
It is very uncertain whether neoadjuvant immunotherapy (talimogene laherparepvec) changes adverse Events, compared with no neoadjuvant treatment (very low certainty).
1 finding from 1 review
Overall response rate (ORR), · stage III and IV cutaneous melanoma
1 finding from 1 review